Kymera Therapeutics Inc. Price to FCF Ratio 2020–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Price to free cash flow (P/FCF) ratio for Kymera Therapeutics Inc. (KYMR): market cap divided by trailing twelve-month free cash flow. As of September 30, 2021 it is 37.69.

From: 09/30/2020To: 03/31/2026

Stock Price

TTM Free Cash Flow

Price to FCF

Kymera Therapeutics Inc. Price to FCF Ratio — FAQ

Kymera Therapeutics Inc. (KYMR) price to fcf ratio over the last 7 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see KYMR's price to fcf ratio history?

The chart and table above show Kymera Therapeutics Inc.'s price to fcf ratio by year and by quarter, including the growth rate.